S.Res. 42 · 109th Congress
A resolution expressing the sense of the Senate on promoting initiatives to develop an HIV vaccine.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
LugarSponsor8 cosponsors · 1 D, 7 R
0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Expresses the sense of the Senate that the President should: (1) mobilize necessary economic and scientific support for the Global HIV Vaccine Enterprise (an alliance of the world's leading scientists and independent organizations committed to accelerating the development of an HIV vaccine by enhancing coordination, information sharing, and collaboration…
What it does: CRS summary · Introduced in Senate · Feb 7, 2005
Expresses the sense of the Senate that the President should: (1) mobilize necessary economic and scientific support for the Global HIV Vaccine Enterprise (an alliance of the world's leading scientists and independent organizations committed to accelerating the development of an HIV vaccine by enhancing coordination, information sharing, and collaboration globally); and (2) urge members of the Group of Eight (Canada, France, Germany, Italy, Japan, Russia, the United Kingdom, and the United States) to garner support from their own communities for the development of an HIV vaccine.
Calls for such countries to: (1) take further measures to explore and implement Enterprise initiatives; (2) leverage financial contributions from the international philanthropic community to provide funding to promote the development of an HIV vaccine; (3) include the scientific and political leadership of the countries most affected by the pandemic of HIV and AIDS; and (4) develop a plan for furthering such efforts prior to their June 2005 meeting.
Urges the President to generate global support for the Global HIV Vaccine Enterprise by carrying out an initiative that: (1) coordinates and partners with member countries, the private sector, and other countries; (2) encourages Group of Eight countries to act swiftly to mobilize resources; (3) includes a strategic plan to prioritize challenges to the development of an HIV vaccine, to coordinate research and product development, and to encourage greater use of information-sharing networks and technologies; (4) encourages the establishment of coordinated global HIV vaccine development centers; and (5) increases cooperation and communication among regulatory agencies on issues related to AIDS and HIV.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: A resolution expressing the sense of the Senate on promoting initiatives to develop an HIV vaccine.
Latest action (Jun 23, 2005): Committee on Foreign Relations. Hearings held. Hearings printed: S.Hrg. 109-292.
Policy area: International Affairs · Origin: Senate · Introduced: Feb 7, 2005
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.